Copper for Copper Deficiency

Yes for blood counts, less so for nerves. Treatment is copper replacement (oral, or intravenous in severe cases) at a clinician-set dose, plus removing the cause, such as excess zinc. In small uncontrolled series, blood counts recovered in most treated patients: 93% of cytopenias in a 16-patient Scottish series (with the cause also treated), and all seven treated patients in an eight-patient series, with counts back to normal in three to four weeks. A 15-patient Japanese series was less clear-cut, with 53% improving. Nerve damage is different: in a systematic review of 198 cases, only 24% improved after supplementation and 5.1% recovered to baseline.

No randomized trial exists, and the cause is usually treated at the same time, so this page rates the evidence limited and the verdict mixed: the blood response is fairly consistent, the nerve response is poor, and dose and duration are untested. In practice replacement belongs in a clinician's hands: confirm the deficiency, find and remove the cause (excess zinc, gut surgery, malabsorption), then replace and recheck. For the condition itself, see our copper deficiency page; for the mineral, the copper page.

Copper is a cofactor for enzymes called cuproenzymes, which are involved in energy production, iron metabolism, neuropeptide activation, connective tissue synthesis and neurotransmitter synthesis. Ceruloplasmin, the main copper-carrying protein, carries more than 95% of the copper in healthy blood plasma (NIH Office of Dietary Supplements). Deficiency arises when copper is not absorbed or not supplied, so replacement restores the missing ingredient. That is why a Mayo Clinic review found copper supplementation resolved anemia and neutropenia 'promptly and completely' (Kumar 2006).

Absorption is also why the cause matters as much as the dose. Copper is absorbed mainly in the upper small intestine. Previous upper gastrointestinal surgery, zinc overload and malabsorption syndromes all impair copper absorption there (Jaiser 2010), and the NIH notes that regular high-dose zinc can cause deficiency because zinc inhibits copper absorption. In the Scottish national series, 12 of 16 patients had high blood zinc and nine used zinc-containing dental fixatives (Gabreyes 2013). Replacing copper without removing the cause risks a relapse.

The sources don't explain why nerve damage resists treatment; they report outcomes. Blood counts recover quickly, while nerve symptoms tend to persist, and the data do show a timing effect. In 15 patients who received 12 months of copper supplementation, the longer symptoms had lasted before treatment, the smaller the gain in daily function (P = 0.005) (Prodan 2011), and a systematic review concluded that neurologic deterioration can be devastating and irreversible even with copper supplementation (Chen 2024).

The adult Recommended Dietary Allowance is 900 mcg (0.9 mg) a day, and the tolerable upper limit is 10 mg a day; the NIH notes that the upper limits do not apply to people receiving copper under medical supervision. Treatment doses in the literature are much higher than the RDA and are not standardized: one man with copper deficiency and high blood zinc recovered his blood counts on 2 mg a day by mouth, but his nerve disease worsened until the dose was raised to 8 mg a day, which partially reversed his neurologic signs (Hedera 2003). After duodenal switch surgery, one patient needed intravenous copper at 4 mg a day plus oral copper gluconate during severe diarrhea, then 4 mg by mouth three times a day (12 mg a day, above the 10 mg upper limit and given under supervision) to stay normal (Btaiche 2011). These are single cases, not recommendations.

The British Obesity and Metabolic Surgery Society guideline is the nearest thing to a protocol. It recommends a complete multivitamin and mineral supplement with 2 mg of copper daily after gastric bypass, sleeve gastrectomy and duodenal switch. For mild deficiency it suggests two daily doses of the UK prescription multivitamin-mineral, which contains 2 mg of copper and 15 mg of zinc per dose, and a recheck after three months; for severe copper deficiency it says to refer for specialist advice (O'Kane 2020). Doubling an over-the-counter multivitamin is not the same thing, so let your clinician choose the product.

Most of the evidence is about anemia and low white cells, and it points the same way. Eight patients referred for unexplained anemia and neutropenia had serum copper below 70 mcg/dL; all seven who were treated with oral copper gluconate responded, seven with a complete remission, and counts normalized in three to four weeks (Huff 2007). In the Scottish national review of 16 patients, 93% of cytopenias responded to copper replacement and treatment of the cause (Gabreyes 2013). A review of 55 case reports found treatment led to hematological normalization, and cytopenias had been present in 78% (Jaiser 2010).

Not every series is as clean. In a Japanese hospital series of 15 patients, 14 received copper, stopped zinc, or both; 11 patients (73% of the 15) reached normal copper levels but only eight (53%) showed hematological improvement (Uchino 2021). Copper deficiency can also resemble myelodysplastic syndrome: seven of the eight patients in the first series had been referred for evaluation of myelodysplasia, and a 40-patient review found that it can masquerade as one while remaining a very treatable cause (Halfdanarson 2008).

The nerve data are the sobering part. A systematic review of 198 cases of copper deficiency myelopathy found that despite appropriate copper supplementation only 47 (24%) improved and 10 (5.1%) recovered to baseline (Chen 2024). In the Scottish series 25% improved, 33% worsened and 42% stayed unchanged (Gabreyes 2013). Ten patients treated with oral copper stabilized rather than improved (Kelkar 2008), and in a 13-patient series copper prevented further deterioration but improvement varied (Kumar 2004). When improvement does occur it is often subjective and mostly involves sensory symptoms (Kumar 2006).

There is a more hopeful signal for function, with caveats. In 15 patients supplemented for 12 months, the Barthel Index of daily living rose from 74 to 83 (P = 0.007), with larger gains when treatment started sooner (Prodan 2011). It had no control group, so natural recovery can't be ruled out.

No randomized or placebo-controlled trial exists, no study compares doses, and none compares copper with simply stopping the zinc or fixing the cause. Case series are prone to reporting bias. The findings still come from many independent centers and countries and agree on the main point, but without a controlled trial the evidence stays limited.

Prevention evidence is a separate question. In 437 bariatric surgery patients told to take multivitamin-mineral supplements, copper deficiency stayed between 0% and 5% (Papamargaritis 2015), and a systematic review concluded that copper deficiency in adequately supplemented gastric bypass patients is rare (Kumar 2016). In a review of 136 gastric bypass patients at the Emory Bariatric Center, 9.6% had copper deficiency, and in 16 followed over time the incidence was 18.8%; the abstract does not report supplement use (Gletsu-Miller 2012). A meta-analysis of 43 studies put the prevalence after metabolic and bariatric surgery at 16%, 28%, 21% and 16% at one, two, three and four years (Xu 2025).

The case reports do not describe side effects of supervised replacement, but they were not designed to look for them, and doses above the 10 mg upper limit were used in some. Chronic high copper intake can cause liver damage and gastrointestinal symptoms such as abdominal pain, cramps, nausea, diarrhea and vomiting, and the upper limit was set from levels linked to liver damage. Copper toxicity is rare in healthy people without a hereditary copper defect (NIH Office of Dietary Supplements). The practical risk is taking copper without confirming a deficiency, or leaving the cause (such as zinc) in place.

For pregnancy and breastfeeding the NIH lists higher needs (RDA 1,000 mcg and 1,300 mcg a day), with the same 10 mg upper limit for adults; for children the upper limits are lower (1 mg at ages 1-3, 3 mg at 4-8, 5 mg at 9-13 and 8 mg at 14-18), and infants should get copper only from breast milk, formula and food. Anyone treating a child, or pregnant, should do so only with a clinician.

The interaction that matters is with zinc, which inhibits copper absorption and is the best-documented cause of supplement-related deficiency. In a placebo-controlled study in healthy men, two daily 25 mg doses of zinc for six weeks lowered erythrocyte Cu,Zn-superoxide dismutase, a copper-enzyme marker, even though plasma copper did not change significantly (Fischer 1984). In 70 patients prescribed zinc, 62% were on doses sufficient to cause copper deficiency and plasma copper had been measured in only two (Duncan 2015). The NIH notes no clinically relevant interactions between copper and medications.

Zinc can also cause trouble when it is a deliberate treatment. Among 338 patients with Wilson disease treated at one centre, three developed copper deficiency, and the literature adds 17 more, all on zinc salts, with symptoms appearing more than a decade after treatment began (Chevalier 2023). Menkes disease is a separate inherited disorder of copper handling, where copper-histidine injections help only if started in the neonatal period (Vairo 2019).